FDA PMA FDA Class 3 Approved 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P920047 · Supplement: S137 · Decision Aug 14, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P920047 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
Blazer™ II Cardiac Ablation System and Cable
PMA Number
P920047
Supplement Number
S137
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 14, 2025
Date Received
July 9, 2025
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

for a manufacturing site located at Boston Scientific de Costa Rica, S.R.L., El Coyol Alajuela, Coyol, Costa Rica (FEI: 3007695959) to perform ethylene oxide sterilization activities

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter